Clinical trial
A Placebo-Controlled Crossover Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
NCT02234011 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo-Controlled Crossover Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
- Lead sponsor
- Mclean Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2014
- Completion date
- January 31, 2016
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.